- €63.33bn
- €71.64bn
- €21.10bn
Germany's Merck KGaA: we are in contact with US to understand tariffs
Brief: Merck Says Kai Beckmann To Succeed Belén Garijo As Chair Of The Executive Board And CEO Of Merck As Of May 2026
Chinese police investigating app fraud case, says German drugmaker Merck KGaA
Brief: Merck KGaA And Siemens Extend Partnership
Brief: Merck KGaA - To Present New Data Highlighting Durable Effects Of Mavenclad® In Rms At Ectrims
Brief: Biocytogen Enters Into Agreement With Merck To Advance Antibody-Conjugated Lipid-Based Delivery Solutions
Europe Research Roundup: Barclays, Kingfisher, Tesco
Barclays cuts Merck to 'equal weight', cites multiple risks ahead of CMD
Europe Research Roundup: Assura, Banco BPM, Metro Bank
Brief: Merck KGaA - European Commission Grants Approval Of Ogsiveo
Media: Merck KGaA plans $4 billion bond sale to fund SpringWorks Therapeutics acquisition - Bloomberg News
Big Pharma has rare shot at bargain hunting
Europe Research Roundup: Hermes, Maersk, Mondi
Germany's Merck falls on Q2 results miss
Merck KGaA raises forex-adj profit guidance on drugs, lab gear (updated)
Brief: Merck KGaA Q2 EPS EUR 1.5
Brief: Merck KGaA Now Expects Organic Growth Of 4% To 8%
European drugmakers fall after Trump raises stakes over US drug price cuts (updated)
Newscasts - European drugmakers rattled over Trump letter on US price cuts